Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Adempas (Riociguat, BAY63-2521)
DRUG
2 trials
Sponsors
Bayer
Conditions
Hypertension, Pulmonary
Phase 4
A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.
Completed
NCT02759419
Bayer
Hypertension, Pulmonary
Start: 2016-06-16
End: 2025-09-15
Updated: 2025-10-03
Unknown Phase
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
NCT01784562
Bayer
Hypertension, Pulmonary
Updated: 2016-01-06
Related Papers
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.
2017-12-28
18 citations